Health TrialsbyHealthPanel

Retrospective Study of Brachytherapy

ConditionsBrachytherapyUterine Cervical NeoplasmsUterine NeoplasmsVulvar CancerVaginal CancerOvarian NeoplasmsGynecologic Neoplasm
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-80
SponsorZhejiang Cancer Hospital

About this trial

Brachytherapy for gynecological cancers will be studied retrospectively.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 - 80 female

Underwent brachytherapy

With gynecological cancer

Disqualifiers

Refusal to enter this trial

Trial population

18 to 80 years old female who diagnosed as gynecological cancer and underwent brachytherapy will be enrolled in this study.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Brachytherapy

    Radiation

    Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy

Treatment groups

300 Participants
are divided into 5 treatment groups
Group A: Cervix radical BT1 intervention
Group B: Cervix adjuvant BT1 intervention
Group C: Cervix palliative BT1 intervention
Group D: Uterus BT1 intervention
Group E: Other GO cancer BT1 intervention

Trial outcomes

Primary outcomes

1

Overall survival rate

the percentage of participants in the group who survives

Time frame
5-year

Secondary outcomes

1

Progression-free survival rate

the percentage of participants in the group whose disease is likely to remain stable

Time frame
5-year
2

Side effects

side effects associated with treatment

Time frame
5-year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Zhejiang Cancer Hospital

Lead sponsor

Source ClinicalTrials.gov
Apply now